<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00297661</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-33/2003</org_study_id>
    <nct_id>NCT00297661</nct_id>
  </id_info>
  <brief_title>Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization</brief_title>
  <official_title>Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization: SIRTAX Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bern</source>
  <brief_summary>
    <textblock>
      Context: Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal
      stents, reduce the risk of restenosis. It is unclear whether there are differences in safety
      and efficacy between the two types of drug-eluting stents.

      Objective: To determine differences in safety and efficacy between sirolimus and paclitaxel
      eluting stents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: Randomized controlled, observer-blind trial comparing sirolimus-eluting stents with
      paclitaxel-eluting stents

      Patients: 1012 patients undergoing percutaneous coronary intervention. The two groups had
      similar baseline clinical and angiographic characteristics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac events at nine months (composite of cardiac death, myocardial infarction or ischemia-driven target lesion revascularization)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical: Ischemia-driven target lesion revascularization, target-vessel revascularization, and target-vessel failure (composite of cardiac death, myocardial infarction or ischemia-driven target-vessel revascularization)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic: In-segment late luminal loss</measure>
  </secondary_outcome>
  <enrollment>1012</enrollment>
  <condition>Coronary Heart Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sirolimus-eluting stent</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Paclitaxel-eluting stent</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with either stable angina or an acute coronary syndrome were eligible to
        participate if they had at least one lesion with stenosis of at least 50 percent in a
        vessel with a reference diameter between 2.25 and 4.00 mm that was suitable for stent
        implantation.

        Exclusion Criteria:

        Allergy to antiplatelet drugs, heparin, stainless steel, contrast agents, sirolimus, or
        paclitaxel; participation in another coronary-device study; and terminal illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Windecker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, University Hospital Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Juni, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Social and Preventive Medicine, University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernhard Meier, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Cardiology, University Hospital Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, Corti R, Sütsch G, Maier W, Lüscher T, Hess OM, Egger M, Meier B. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005 Aug 18;353(7):653-62. Epub 2005 Aug 16.</citation>
    <PMID>16105989</PMID>
  </results_reference>
  <verification_date>February 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2006</study_first_submitted>
  <study_first_submitted_qc>February 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2006</study_first_posted>
  <last_update_submitted>October 19, 2006</last_update_submitted>
  <last_update_submitted_qc>October 19, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2006</last_update_posted>
  <keyword>Coronary Revascularization</keyword>
  <keyword>Sirolimus-eluting stents</keyword>
  <keyword>Paclitaxel-eluting stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
    <mesh_term>Sirolimus</mesh_term>
    <mesh_term>Everolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

